Spectrum pharma stock.

Symbol Lookup from Yahoo Finance. Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.May 9, 2023 · 107,675. $. 103,338. BOSTON, May 09, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a commercial stage biopharmaceutical company focused on novel and targeted oncology therapies, announced ... Dec 28, 2022 · On this news, shares of Spectrum common stock declined from a closing price of $1.06 per share on September 19, 2022, to a close at $0.66 per share on September 20, 2022, a decline of $0.40 per ... If you’re looking to get the most out of your Spectrum broadband plan, there are a few things you can do. Some simple tips include using the internet wisely, being aware of your internet usage, and looking for deals. But they go a bit deepe...Check out our SPPI stock analysis, current SPPI quote, charts, and historical prices for Spectrum Pharma Inc stock

Spectrum Pharmaceuticals regains compliance with Nasdaq minimum bid price requirement Seeking Alpha 176d Spectrum Pharmaceuticals GAAP EPS of -$0.02 beats by $0.03, revenue of $15.6M beats by $1.44MThe Spectrum Pharmaceuticals class action lawsuit (Luo v. Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc. , No. 2:21-cv-01612) was commenced on August 31, 2021 in the District of Nevada.Jul 24, 2023 · Spectrum stockholders will receive 0.1783 shares of Assertio stock for each share of Spectrum stock they own, an upfront value of $1.14 and an initial 65% premium to Spectrum’s closing price.

Price/Book 7.89 Trade SPPI with: Price/Earnings ttm 0.00 Earnings Per Share ttm -0.37 Most Recent Earnings -0.02 on 05/09/23 Next Earnings Date 08/10/23 Annual Dividend & Yield N/A (0.00%) Most Recent Dividend 0.150 on 12/18/12 Sectors: Options Overview Details View History Implied Volatility 0.00% ( unch) Historical Volatility 41.98%

The biopharmaceutical company earned $137.10 million during the quarter, compared to analyst estimates of $97.66 million. GW Pharmaceuticals had a negative trailing twelve-month return on equity of 7.46% and a negative net margin of 11.05%. The company's revenue for the quarter was up 50.7% on a year-over-year basis.That deal values SPPI stock at $1.34 per share, which is a 94% premium over the stock’s closing price on Monday. It also brings the total value of the deal to $291 million. When the deal closes ...Jan 17, 2019 · The seven products are Fusilev (levoleucovorin), Folotyn (pralatexate injection), Zevalin (ibritumomab tiuxetan), Marqibo (vincristine sulfate LIPOSOME injection), Beleodaq (belinostat) for injection, Evomela (melphalan) for injection, and Khapzory (levoleucovorin). The seven drugs had a combined sales of $76.4 million in the first three ... Wall Street Stock Market & Finance report, prediction for the future: You'll find the Spectrum Pharmaceuticals share forecasts, stock quote and buy / sell signals below. According to present data Spectrum Pharmaceuticals's SPPI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

Spectrum Pharmaceuticals's stock symbol is SPPI What is Spectrum Pharmaceuticals's official website? Spectrum Pharmaceuticals's official website is www.sppirx.

The latest closing stock price for Spectrum Pharmaceuticals, Inc. on July 31, 2023 is 1.03. The all-time high Spectrum Pharmaceuticals, Inc. closing stock price was 598.32 on March 07, 2000. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.

Jul 31, 2023 · Spectrum Pharmaceuticals, Inc. : News, information and stories for Spectrum Pharmaceuticals, Inc. | Nasdaq: SPPI | Nasdaq May 17, 2023 · Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical Company focused on novel and targeted oncology anno Spectrum Pharmaceuticals is an American biopharmaceutical company located in Boston, MA. It develops and markets drugs for treatments in hematology and oncology . After a deal valued at $248 million was announced in April 2023, [1] [2] Assertio Holdings announced that it had completed its acquisition of the Massachusetts -based company on July 31.In addition, Spectrum stockholders will get one CVR per Spectrum share entitling them to receive up to an additional $0.20 per share in total (~$43M), payable in cash or stock at Assertio's ...Near term upsides for Aurobindo Pharma stock capped on weak US outlook. 4 min read Last Updated : Aug 14 2021 ... Reliance Jio close Rs 1,004-crore spectrum trading deal. 2 min read Last Updated : Aug 13 2021 | 11:45 ... Intense price competition in US generics market hits Indian pharma. 5 min read Last Updated : Aug 13 2021 | 9:08 PM …

SPECTRUM PHARMACEUTICALS, INC. COMMON STOCK Our common stock is traded on the Nasdaq SmallCap Market under the symbol “SPPI.” On September 8, 2003, the closing price of our common stock was $5.10. This prospectus relates to the sale of up to 1,270,429 shares of our common stock by the selling stockholders named in this prospectus. Spectrum Pharma Stock (NASDAQ: SPPI)The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to …05/10/2023 Third Quarter 2023 Financial Results 11/08/2023 Second Quarter 2023 Financial Results 08/03/2023 Annual Meeting of Stockholders 05/10/2023 Latest Presentation Quarterly Results Q3 2023 Earnings Release View All ResultsThe average twelve-month price prediction for Spectrum Pharmaceuticals is $2.44 with a high price target of $4.00 and a low price target of $0.75. Learn more on SPPI's analyst rating history. Do Wall Street analysts like Spectrum Pharmaceuticals more than …It also withdrew its outlook for the full year of 2023! Assertio (NASDAQ: ASRT) stock is falling hard on Friday after the pharmaceutical company released its second-quarter earnings report ...Apr 25, 2023 · Colin Behrens från Pixabay. Assertio Holdings has reached a definitive agreement to purchase all outstanding shares of Spectrum Pharmaceuticals in an all-stock and contingent value rights (CVR) deal. Spectrum is a commercial-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel and targeted ...

We would like to show you a description here but the site won’t allow us.

May 9, 2023 · Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a commercial stage biopharmaceutical company focused on novel and targeted oncology therapies, announ ... Common stock, $0.001 par value ... will acquire Spectrum Pharmaceuticals Inc SPPI in an all-stock and contingent value rights (CVR) transaction. Under the terms of the agreement, each Spectrum share will be exchanged for a...Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the first patient has been dosed in Japan in a Nippon Kayaku sponsored Phase 1 study of apaziquone in bladder cancer.Spectrum Pharma (SPPI) reported Q1 2023 earnings per share (EPS) of-$0.02, beating estimates of -$0.06 by 61.25%. In the same quarter last year, Spectrum Pharma 's earnings per share (EPS) was -$0.09 .Stocks that have been delisted from the US stock market. Some have gone bankrupt or been acquired, others have been delisted for other reasons. ... Spectrum Pharmaceuticals Inc: Jul 31, 2023: REUN: Reunion Neuroscience Inc: Jul 31, 2023: OFED: Oconee Federal Financial Corp: Jul 31, 2023: HMPT: Home Point Capital Inc: Jul 27, …Spectrum is a popular broadband internet company that offers high-speed internet, mobile phone, and television services. Spectrum offers a variety of television services, including live and on-demand TV. So, there’s a variety of channels th...

Symbol Lookup from Yahoo Finance. Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.

Real time Spectrum Pharmaceuticals (SPPI) stock price quote, stock graph, news & analysis.

Apr 25, 2023 · Assertio Holdings Inc (NASDAQ: ASRT) will acquire Spectrum Pharmaceuticals Inc (NASDAQ: SPPI) in an all-stock and contingent value rights (CVR) transaction. Under the terms of the agreement, each ... Spectrum shareholders will receive 1.1783 shares of Assertio stock for each share of Spectrum stock they own, the companies said. The deal is worth approximately $248 million.Equities. Stock Spectrum Pharmaceuticals, Inc. - Nasdaq. Spectrum Pharmaceuticals, Inc. (SPPI.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Spectrum Pharmaceuticals, Inc. | Nasdaq: SPPI | Nasdaq. Spectrum Pharmaceuticals is an American biopharmaceutical company located in Boston, MA. It develops and markets drugs for treatments in hematology and oncology. After a deal valued at $248 million was announced in April 2023, Assertio Holdings announced that it had completed its acquisition of the Massachusetts-based …Nov 21, 2023 · bizjournals.com - April 25 at 1:59 PM. Assertio Scoops Up Spectrum Pharma In $248M Stock Deal. finance.yahoo.com - April 25 at 1:59 PM. Assertio Holdings To Acquire Spectrum Pharmaceuticals; ASRT Stock Tumble In Pre-market. markets.businessinsider.com - April 25 at 8:58 AM. We would like to show you a description here but the site won’t allow us.Spectrum Pharmaceuticals Stock Price Chart Technical Analysis: Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPPI is experiencing slight buying pressure.Apr 25, 2023 · Spectrum Pharmaceuticals (NASDAQ:SPPI) stock is soaring after an all-stock acquisition deal with Assertio Holdings was announced Tuesday morning. The $248 million purchase price values Spectrum shares at $1.14 each, a significant premium over its Tuesday closing price of $0.69. The stock price surged more than 30% to $0.90 Tuesday morning. Complementary Commercial Growth Platforms Anticipated to Accelerate ROLVEDON™ (eflapegrastim-xnst) Injection Profitability and Diversify Revenue StreamsMay 9, 2023 · 107,675. $. 103,338. BOSTON, May 09, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a commercial stage biopharmaceutical company focused on novel and targeted oncology therapies, announced ... Spectrum Pharmaceuticals is a biopharmaceutical company whose products under development include, among others, ROLONTIS (eflapegrastim), a novel long-acting granulocyte colony-stimulating factor ...Spectrum Pharmaceuticals is an American biopharmaceutical company located in Boston, MA. It develops and markets drugs for treatments in hematology and oncology . After a deal valued at $248 million was announced in April 2023, [1] [2] Assertio Holdings announced that it had completed its acquisition of the Massachusetts -based company on July 31.

With so many channels available on Spectrum, it can sometimes be overwhelming to navigate through the options and find the ones that cater to your interests. Whether you’re a news junkie, a sports enthusiast, or a movie buff, Spectrum has s...On this news, Spectrum Pharmaceuticals’ stock price fell 31% to close at $0.43 per share on September 23, 2022, on unusually heavy trading volume.🇺🇸 🕒 пн, 7 мар. 2022 г., 19:30:05 MSK Outlook on the Oral Cancer Treatment Global Market to 2030 - Increase in Number of Pipeline Drugs Presents Opportunities DUBLIN, March 7, 2022 /PRNewswire/ -- The "Oral Cancer Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's …Find the latest Xeris Biopharma Holdings, Inc. (XERS) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. good business names for llcbest option trading trainingsandp 500 ytd 2023 returnwhat company makes wegovy Spectrum Pharmaceuticals (NASDAQ: SPPI), a small-cap oncology company, saw its shares gain a whopping 39.2% in October, according to S&P; Global Market Intelligence. The drugmaker's stock took ... fastest mercedes sedanhyundai stocks Shares of small-cap drug maker Spectrum Pharmaceuticals ... Fintel’s consensus forecast price target of $3.16 suggests the stock could see a further 350% upside over 2022. The chart provided ... voo dividend per share We would like to show you a description here but the site won’t allow us.Spectrum Equity provides growth capital and expertise to market leading companies.